Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

Share Price Information for Biome Tech (BIOM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 75.00
Bid: 70.00
Ask: 80.00
Change: -2.50 (-3.23%)
Spread: 10.00 (14.286%)
Open: 77.50
High: 77.50
Low: 75.00
Prev. Close: 77.50
BIOM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

27 Jun 2016 07:00

RNS Number : 2776C
Biome Technologies PLC
27 June 2016
 

27 June 2016

 

 

Biome Technologies plc

("Biome", the "Company" or the "Group")

 

Trading Update

 

 

Biome Technologies plc, a leading bioplastics and radio frequency technology business, today publishes a trading update for the six month period ending 30 June 2016. This update is being made ahead of the period end and in place of the trading update scheduled for the end of July. The interim results are expected to be announced on 31 August 2016.

 

Trading Update

Total Group revenues for the first half are expected to be £2.2m (H1 2015 £2.1m). Whilst this revenue is marginally ahead of last year's performance, it is below that of the Board's expectations. This shortfall is due to a reduced demand for already commercialised products in the Bioplastics Division and some slippage of the Stanelco RF's division's order pipeline into the second half.

 

The Group's cash position at 27 June 2016 is £1.0m (31 March 2016: £1.6m) reflecting the current trading activity and timing of anticipated cash receipts from work in progress in the Stanelco RF division.

 

Bioplastics Division

Revenues generated by the Bioplastics Division in the first half of 2016 totalled £0.6m (H1 2015 £1.0m).

It was noted in the trading update of 25 April 2016 that revenues in the Bioplastics division in the first quarter of 2016 were £0.2m (Q1 2015: £0.5m) reflecting the timings of campaign production runs of packaging and lidding materials for the US single-serve coffee market (coffee pods). Whilst revenues recovered in Q2 2016 to £0.4m with some additional campaigns, it had been expected by the Board that this recovery would be stronger.

 

Biome has been developing a suite of related materials to enable coffee pod producers to sell biodegradable end products to the US consumer market. This is an important advance for the market and has received supportive media comment. The materials Biome has been developing comprise the outer packaging and the lid, ring and "non-woven" filter of the pod. Each part has entailed significant development cost both in time and in production testing and we have worked in a collaborative way with the manufacturers of the pods and packaging in the US to achieve success. The packaging and lid materials have completed their development stages and have been in full production from the middle of last year. The ring and filter materials are in the advanced stages of development and we expect to move into commercialisation by the end of this year with these materials. Whilst the second half of this year should be favourably impacted as the ring reaches its commercialisation phase, it has now become clear that the inflexion point of significant revenue generation will be later in the half year than the Board has previously expected as Biome's customers complete their own work to industrialise this innovative product.

 

Throughout this broad programme, Biome has been continually re-assessing the likely demand for the portfolio of the Bioplastics division's materials, although this is made difficult by fluctuating underlying market growth, the rise in demand for such bio-degradable products as they become available and, contrarily, improving efficiencies in our customers' production processes. The Group has just completed such a review and the Board continues to believe that the long-term outlook for these products remains very positive. In the short term, however, it believes the likely demand will be less than originally thought. This will result in a near-term fall in anticipated revenues. A similar review will be undertaken at the end of August, prior to the Group's Interim Statement.

 

Stanelco RF Technologies Division

Revenues for this division in the first half of 2016 were £1.6m (2015: £1.3m), slightly behind the Board's expectations. Whilst a number of the prospective orders for the second half are still being finalised, the division has a healthy enquiry book forward into 2017.

 

Group Outlook

Group revenues at the mid-year point are behind the Board's expectations. Whilst margins have been robust and the operating loss for the period is anticipated to be lower than for the same period in 2015, it will be behind the Board's expectations.

 

Whilst the Board is confident that revenue growth should accelerate in the second half of the year, it is now likely that the Group's full year performance will be significantly behind current market expectations, with the Board now expecting Group revenues for the year to 31 December 2016 to be only marginally ahead of those achieved in the prior year.

 

 

- Ends -

 

 

For further information please contact:

 

Biome Technologies plc

Paul Mines, Chief Executive Officer

Declan Brown, Group Finance Director

www.biometechnologiesplc.com

Tel: +44 (0) 2380 867 100

 

Allenby Capital

David Hart/Richard Short (Nominated Adviser)

Chris Crawford/Kelly Gardiner (Broker)

www.allenbycapital.com

Tel: +44 (0) 20 3328 5656

 

FTI Consulting

Oliver Winters

www.fticonsulting.com

Tel: +44 (0) 20 3727 1535

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTAKADNFBKDFAB
Date   Source Headline
25th Mar 20207:00 amRNSUpdate re Final Results, 2019 Annual Report & AGM
13th Feb 20204:01 pmRNSNotification of awards under the 2017 LTIP
30th Jan 20204:10 pmRNSShare option awards in lieu of historic bonuses
30th Jan 20207:00 amRNSTrading statement and Board change
4th Nov 20197:00 amRNSBiome to present at Mello London 2019
31st Oct 20195:30 pmRNSTotal Voting Rights
31st Oct 20197:00 amRNSTrading update
30th Sep 20193:04 pmRNSResult of General Meeting
12th Sep 20197:05 amRNSProposed Placing to raise £1.3 million
12th Sep 20197:00 amRNSInterim Results
22nd Jul 20197:00 amRNSTrading Update
25th Jun 20199:17 amRNSLong Term Incentive Plan Second Vesting
17th Jun 20194:12 pmRNSDirector/PDMR/PCA Shareholding
14th Jun 20197:00 amRNSBioplastics Product Update
24th Apr 20191:59 pmRNSResult of Annual General Meeting
24th Apr 20197:00 amRNSTrading Update
4th Apr 201912:20 pmRNSDirector/PDMR/PCA Shareholding
29th Mar 20199:22 amRNSNotice of AGM and Annual Report
28th Mar 20197:00 amRNSPreliminary Results
27th Mar 20192:05 pmRNSSecond Price Monitoring Extn
27th Mar 20192:00 pmRNSPrice Monitoring Extension
13th Mar 20191:54 pmRNSHoldings in Company
24th Jan 20197:00 amRNSPre-close Trading Statement
31st Dec 20187:00 amRNSTotal Voting Rights
10th Dec 20182:35 pmRNS2017 Long Term Incentive Plan - First Vesting
6th Dec 20187:00 amRNSGrant funding from Innovate UK
23rd Nov 201812:38 pmRNSBiome to present at Mello London
1st Nov 20187:00 amRNSTrading update
3rd Sep 20187:00 amRNSInterim Results
23rd Jul 20187:00 amRNSTrading Update
31st May 20185:00 pmRNSTotal Voting Rights
2nd May 20184:13 pmRNSIssue of shares to directors & PDMR shareholdings
2nd May 20183:27 pmRNSProposed issue of shares to directors and dealings
24th Apr 201810:40 amRNSResult of Annual General Meeting
24th Apr 20187:00 amRNSTrading update
28th Mar 20181:52 pmRNSNotice of AGM and Annual Report and Accounts
27th Mar 20187:00 amRNSPreliminary Results
19th Feb 20182:05 pmRNSSecond Price Monitoring Extn
19th Feb 20182:00 pmRNSPrice Monitoring Extension
25th Jan 20187:00 amRNSPre-close Trading Statement
21st Dec 20177:00 amRNSNew LTIP and option grant
1st Nov 20177:00 amRNSTrading Update
4th Sep 20177:00 amRNSHalf-year Report
26th Jul 20179:30 amRNSDirector/PDMR Shareholding
25th Jul 20174:50 pmRNSDirector/PDMR Shareholding
24th Jul 20177:00 amRNSTrading Update
24th Apr 201710:45 amRNSResult of AGM
24th Apr 20177:00 amRNSTrading Update
31st Mar 20172:50 pmRNSNotice of AGM and Annual Report and Accounts
29th Mar 20177:00 amRNSPreliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.